Background: The variability in the distribution of the null phenotypes of GSTM1 and GSTT1, due to total or partial gene deletion resulting in the lack of the active enzyme, has been reported in different populations, especially in ethnically well-defined groups but not in Tabuk. This study investigated the variability in the distribution of the null phenotypes of GSTM1 and GSTT1 in the population of Tabuk (northwestern part of Saudi Arabia). Method: This study was conducted on 200 subjects of Tabuk—northwestern part of Saudi Arabia among which 100 were chronic smokers and 100 were nonsmokers. The subjects were reporting to hospital for routine checkup. All were without past history of any chronic disease and no significant abnormality. GST genotyping was done by multiplex PCR-based methods. The smoker and control groups were compared using a chi-square test with P < 0.05. Results: The distribution of the GSTM1 null genotype was more frequent among non smoker individuals (14%) than among smoker individuals (1%) and difference was statistically significant (P < 0.0001) whereas the distribution of the GSTT1 null genotype showed the highest frequency among non smokers (28%) than the smokers (6%) and the difference was statistically significant (P < 0.003). GSTM1 deletion homozygosity of 14% and 1% was reported among non smokers and smokers, respectively whereas GSTT1 deletion homozygosity of 28% and 6% was reported among non smokers and smokers, respectively. Our results indicate that there are major differences in allelic distribution of GSTM1 and GSTT1 genes between the two groups investigated. Combined analysis of both genes revealed that 15% of smokers and non smokers harbor the deleted genotype of GSTM1 and 34% of smokers and non smokers harbor the deleted genotype of GSTT1 with significant differences. Conclusion: This study enables selecting subgroups among the general population who are more susceptible to DNA damage and will help genetic studies on the association of GST polymorphisms with disease risks and drug effects in Arab population. Studies with a larger sample size are needed to evaluate and confirm the validity of our results.
References
[1]
Singh, M.S. and Michael, M. (2009) Role of Xenobiotic Metabolic Enzymes in Cancer Epidemiology. Methods in Molecular Biology, 472, 243-264. http://dx.doi.org/10.1007/978-1-60327-492-0_10
[2]
Board, P.G. and Menon, D. (2013) Glutathione Transferases, Regulators of Cellular Metabolism and Physiology. Biochimica et Biophysica Acta, 830, 3267-3288. http://dx.doi.org/10.1016/j.bbagen.2012.11.019
[3]
Hayes, J.D., Flanagan, J.U. and Jowsey, I.R. (2005) Glutathione Transferases. Annual Review of Pharmacology and Toxicology, 45, 51-88. http://dx.doi.org/10.1146/annurev.pharmtox.45.120403.095857
[4]
Board, P., Coggan, M., Johnston, P., Ross, V., Suzuki, T. and Webb, G. (1990) Genetic Heterogeneity of the Human Glutathione Transferases: A Complex of Gene Families. Pharmacology & Therapeutics, 48, 357-369. http://dx.doi.org/10.1016/0163-7258(90)90054-6
[5]
Pemble, S., Schroeder, K.R., Spencer, S.R., Meyer, D.J., Hallier, E., Bolt, H.M., Ketterer, B. and Taylor, J.B. (1994) Human Glutathione S-Transferase Theta (GSTT1): cDNA Cloning and the Characterization of a Genetic Polymorphism. Biochemical Journal, 300, 271-276. http://dx.doi.org/10.1042/bj3000271
[6]
Gattás, G.J.F., Kato, M., Soares-Vieira, J.A., Siraque, M.S., Koher, P., Gomes, L., Rego, M.A.V. and Bydlowske, S.P. (2004) Ethnicity and Glutathione S-Transferase (GSTM1/GSTT1) Polymorphisms in a Brazilian Population. Brazilian Journal of Medical and Biological Research, 37, 451-458. http://dx.doi.org/10.1590/S0100-879X2004000400002
[7]
Harries, L.W., Stubbins, M.J., Forman, D., Howard, G.C. and Wolf, C.R. (1997) Identification of Genetic Polymorphisms at the Glutathione S-Transferase Pi Locus and Association with Susceptibility to Bladder, Testicular and Prostate Cancer. Carcinogenesis, 18, 641-644. http://dx.doi.org/10.1093/carcin/18.4.641
[8]
Rebbeck, T.R. (1997) Molecular Epidemiology of the Human Glutathione S-Transferase Genotypes GSTM1 and GSTT1 in Cancer Susceptibility. Cancer Epidemiology Biomarkers & Prevention, 6, 733-743.
[9]
Garte, S., Gaspari, L., Alexandrie, A.K., et al. (2001) Metabolic Gene Polymorphism Frequencies in Control Populations. Cancer Epidemiology Biomarkers & Prevention, 10, 1239-1248.
[10]
Engel, L.S., Taioli, E., Pfeiffer, R., et al. (2002) Pooled Analysis and Meta-Analysis of Glutathione S-Transferase M1 and Bladder Cancer: A HuGE Review. American Journal of Epidemiology, 156, 95-109. http://dx.doi.org/10.1093/aje/kwf018
[11]
Geisler, A.S. and Olshan, A.F. (2001) GSTM1, GSTT1, and the Risk of Squamous Cell Carcinoma of the Head and Neck: A Mini-HuGE Review. American Journal of Epidemiology, 154, 95-105. http://dx.doi.org/10.1093/aje/154.2.95
[12]
Reszka, E. and Wasowicz, W. (2001) Significance of Genetic Polymorphisms in Glutathione S-Transferase Multigene Family and Lung Cancer Risk. International Journal of Occupational Medicine and Environmental Health, 14, 99-113.
[13]
Knudsen, L.A., Loft, S.H. and Autrup, H. (2001) Risk Assessment: The Importance of Genetic Polymorphisms in Man. Mutation Research, 483, 83-88. http://dx.doi.org/10.1016/S0027-5107(01)00213-5
[14]
Cotton, S.C., Sharp, L., Little, J. and Brockton, N. (2000) Glutathione S-Transferase Polymorphisms and Colorectal Cancer: A HuGE Review. American Journal of Epidemiology, 151, 7-32. http://dx.doi.org/10.1093/oxfordjournals.aje.a010124
[15]
Roy, B., Majumder, P.P., Dey, B., Chakraborty, M., Banerjee, S., Roy, M., Mukherjee, N. and Sil, S.K. (2001) Ethnic Differences in Distributions of GSTM1 and GSTT1 Homozygous “Null” Genotypes in India. Human Biology, 73, 443-450. http://dx.doi.org/10.1353/hub.2001.0040
[16]
Bell, D.A., Taylor, J.A., Paulson, D.F., Robertson, C.N., Mohler, J.L. and Lucier, G.W. (1993) Genetic Risk and Carcinogen Exposure: A Common Inherited Defect of the Carcinogen-Metabolism Gene Glutathione S-Transferase M1(GSTM1) that Increases Susceptibility to Bladder Cancer. Journal of the National Cancer Institute, 85, 1159-1164. http://dx.doi.org/10.1093/jnci/85.14.1159
[17]
Wilson, W.H., Grant, P.J., Kain, K., Warner, D.P. and Wild, C.P. (2003) Association between the Risk of Coronary Artery Disease in South Asians and a Deletion Polymorphism in Glutathione S-Transferase M1. Biomarkers, 8, 43-50. http://dx.doi.org/10.1080/1354750021000042439
[18]
Strange, R.C. and Fryer, A.A. (1999) The Glutathione S-Transferases: Influence of Polymorphism on Cancer Susceptibility. IARC Scientific Publications, 148, 231-249.
[19]
Sreeja, L., Syamala, V., Hariharan, S., Madhavan, J., Devan, S.C. and Ankathil, R. (2005) Possible Risk Modification by CYP1A1, GSTM1 and GSTT1 Gene Polymorphisms in Lung Cancer Susceptibility in a South Indian Population. Journal of Human Genetics, 50, 618-627. http://dx.doi.org/10.1007/s10038-005-0303-3
[20]
Their, R., Brüning, T., Roos, P.H., Rihs, H.P., Golka, K., Ko, Y. and Bolt, H.M. (2003) Markers of Genetic Susceptibility in Human Environmental Hygiene and Toxicology: The Role of Selected CYP, NAT and GST Genes. International Journal of Hygiene and Environmental Health, 206, 149-171. http://dx.doi.org/10.1078/1438-4639-00209
[21]
Brockmoller, J., Cascorbi, I., Kerb, R. and Roots, I. (1996) Combined Analysis of Inherited Polymorphisms in Arylamine N-Acetyltransferse 2, Glutathione S-Transferases M1 and T1, Microsomal Epoxide Hydrolase, and Cytochrome P450 Enzymes as Modulators of Bladder Cancer Risk. Cancer Research, 56, 3915-3925.
[22]
Hecht, S.S. (2003) Tobacco Carcinogens, Their Biomarkers and Tobacco-Induced Cancer. Nature Reviews Cancer, 3, 733-744. http://dx.doi.org/10.1038/nrc1190
[23]
Poulsen, M.T. and Loew, G.H. (1981) Quantum Chemical Studies of Methyl and Fluoro Analogs of Chrysene: Metabolic Activation and Correlation with Carcinogenic Activity. Cancer Biochemistry Biophysics, 5, 81-90.
[24]
Salem, A.H., Yaqoob, A., Ali, M., Handu, S., Fadel, R., Abu-Hijleh, M. and Almawi, W. (2011) Genetic Polymorphism of the Glutathione S-Transferase M1 and T1 Genes in Three Distinct Arab Populations. Disease Markers, 31, 311-316.
[25]
Gara, S., Abessi, M., Bendjemena, K., Abdennebi, M. and Guemira, F. (2010) Deletion Polymorphism of Glutathione S-Transferases M1 and T1 in the Tunisian Population. La Tunisie Medicale, 88, 700-702.
[26]
Mishara, D.K., et al. (2004) Allelic Variation of GSTT1, GSTM1 and GSTP1 Genes in North Indian Population. Asian Pacific Journal of Cancer Prevention, 5, 362-365.
[27]
Welfare, M., Adeokun, A.M., Bassendine, M.F. and Dali, A.K. (1999) Polymorphisms in GSTP1, GSTM1 and GSTT1 and Susceptibility to Colorectal Cancer. Cancer Epidemiology, Biomarkers & Prevention, 8, 289-292.
[28]
Steinhoff, C., Franke, K.H., Golka, K., et al. (2000) Glutathione Transferase Isozyme Genotypes in Pa-tients with Prostate and Bladder Carcinoma. Archives of Toxicology, 74, 521-526. http://dx.doi.org/10.1007/s002040000161
[29]
Ada, A.O., Suzen, S.H. and Iscan, M. (2004) Polymorphisms of Cytochrome P4501A1, Glutathione S-Transferases M1 and T1 in a Turkish Population. Toxicology Letters, 151, 311-315. http://dx.doi.org/10.1016/j.toxlet.2003.12.075
[30]
Kiyohara, C., Yamamura, K., Nakanishi, Y., Takayama, K. and Hara, N. (2000) Polymorphism in GSTM1, GSTT1 and GSTP1 and Susceptibility to Lung Cancer in a Japanese Population. Asian Pacific Journal of Cancer Prevention, 1, 293-298.
[31]
Millikan, R., Pittman, G., Tse, C.K., Savitz, D.A., Newman, B. and Bell, D. (2000) Glutathione Stransferases M1, T1, and P1 and Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention, 9, 567-573.
[32]
Sctiawan, V.W., Zhang, Z.F., Yu, G.P., et al. (2000) GSTT1 and GSTM1 Null Genotypes and Risk of Gastric Cancer: A Case Control Study in a Chinese Population. Cancer Epidemiology, Biomarkers & Prevention, 9, 73-80.
[33]
Rossini, A., Rapozo, D.C.M., Amorim, L.M.F., et al. (2002) Frequencies of GSTM1, GSTT1, and GSTP1 Polymorphisms in a Brazilian Population. Genetics and Molecular Research, 1, 233-240.
[34]
D’Alo, F., Voso, M.T., Guidi, F., et al. (2004) Polymorphisms of CYP1A1 and Glutathione S-Transferase and Susceptibility to Adult Acute Myeloid Leukemia. Haematologica, 89, 664-670.
[35]
Gsur, A., Haidinger, G., Hinteregger, S., et al. (2001) Polymorphisms of Glutathione-S-Transferase Genes (GSTP1, GSTM1 and GSTT1) and Prostate Cancer Risk. International Journal of Cancer, 95, 152-155. http://dx.doi.org/10.1002/1097-0215(20010520)95:3<152::AID-IJC1026>3.0.CO;2-S
[36]
Vettriselvi, V., Vijayalakshmi, K., Solomon Fd, P. and Venkatachalam, P. (2000) Genetic Variation of GSTM1, GSTT1 and GSTP1 Genes in a South Indian Population. Asian Pacific Journal of Cancer Prevention, 7, 325-328.
[37]
Hamdy, S.I., Hiratsuka, M., Narahara, K., Endo, N., El-Enany, M., Moursi, N., Ahmed, M.S. and Mizugaki, M. (2003) Genotype and Allele Frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian Population. British Journal of Clinical Pharmacology, 55, 560-569. http://dx.doi.org/10.1046/j.1365-2125.2003.01786.x
[38]
Duggan, C., Ballard-Barbash, R., Baumgartner, R.N., Baumgartner, K.B., Bernstein, L. and McTiernan, A.(2013) Associations between Null Mutations in GSTT1 and GSTM1, the GSTP1 Ile(105)Val Polymorphism, and Mortality in Breast Cancer Survivors. Springerplus, 11, 450.
[39]
Wild, C.P., Yin, F., Turner, P.C., Chemin, I., Chapot, B., Mendy, M., Whittle, H., Kirk, G.D. and Hall, A.J. (2000) Environmental and Genetic Determinants of Aflatoxin-Albumin Adducts in the GAMBIA. International Journal of Cancer, 86, 1-7. http://dx.doi.org/10.1002/(SICI)1097-0215(20000401)86:1<1::AID-IJC1>3.0.CO;2-I
